% | $
Quotes you view appear here for quick access.


you are viewing a single comment's thread.

view the rest of the posts
  • toddly_fund toddly_fund Feb 23, 2007 4:33 AM Flag

    CMED, a hodgepodge company!

    CMED's gross profit margins are much higher than MR's, an indication that CMED sells a better product.

    CMED's selling expenses are almost negligible compared with MR. Thusly, CMED's operating margins are about double MR's, an indication that CMED sells much better products.

    CMED has a CFO. Why don't you ask him about the accounting.

    < Mr. Takyung (Sam) Tsang joined our company as our chief financial officer in January 2005. Mr. Tsang was an advisor to the company for the areas of accounting and finance from February 2004 to December 2004. Prior to joining us, Mr. Tsang worked as a manager of KPMG Hong Kong from March 2001 to January 2004, and also worked as a manager of Ernst & Young China from January 1999 to February 2001. Mr. Tsang is a member of the American Institute of Certified Public Accountants and the Hong Kong Institute of Certified Public Accountants. Mr. Tsang received his bachelor's degree in business administration from the Chinese University of Hong Kong. >

    If you want poor disclosure, look at CHINA.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • My problem is not with CMED�s own CFO. He is probably a good man but he is also an employee and gets paid from CMED. The question was about independent accounting companies that certify companies� accounts. Otherwise, it is like fox guarding chickens! CFOs are not angels, my friend! Double-checking of books is very very important!

    • toddly: Good Post.

      However biased, it is ALWAYS good to have opposing views on this board...just to keep us in reality. We'll know soon whether this rocket ship has the fuel to get off the ground.

      Saleem, I think the mother of all resistance is at 29. Also, I wouldn't count on Tuesday as the mother of all dates for this stock to react. Why? Just because everyone thinks it will be. We may get a delayed reaction of up to a few days.

      • 1 Reply to idreamalot2
      • Hi Idreamalot2,

        Thanks for your take on CMED future MOVES.

        I am very SURPRISED that none of the analyst of UBS & CREDIT SUISSE who are lead UNDERWRITERS of CMED has said anything POSITIVE lately.

        I was EXPECTING either an UPGRADE or UPPING of price TARGET for CMED.......

        It is interesting when you & I are both CAUTIOUS about CMED price appreciation......could we both be WRONG?

        The only FUNDAMENTAL reason which comes to my mind is some ACQUISITION RELATED cost for Q4....which may be tempering Analyst ENTHUSIASM in the SHORT TERM.

        I see STRONG growth in CMED business from Q1 imho.

        I guess Tuesday @ 830AM we will be able to EVALUATE the Q4 GUIDANCE by CMED.......